<unk>  is a combination of an anticholinergic and beta-adrenergic that is FDA approved for the {{{indicationType}}} of chronic obstructive pulmonary disease (COPD).   Common adverse reactions include upper respiratory infection, nasopharyngitis, cough, bronchitis, headache, and dyspnea.
Ipratropium Bromide And Albuterol
Budesonide And Formoterol Fumarate Dihydrate
Emedastine Difumarate
Methacholine
Seratrodast
Glycopyrrolate and formoterol fumarate
Levosalbutamol
Pranlukast